AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 271: H1786-H1794, 1996;
0363-6135/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cleveland, J. C.
Right arrow Articles by Banerjee, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cleveland, J. C., Jr
Right arrow Articles by Banerjee, A.

AJP - Heart and Circulatory Physiology, Vol 271, Issue 5 1786-H1794, Copyright © 1996 by American Physiological Society


ARTICLES

Ischemic preconditioning in human and rat ventricle

J. C. Cleveland Jr, M. M. Wollmering, D. R. Meldrum, R. T. Rowland, T. F. Rehring, B. C. Sheridan, A. H. Harken and A. Banerjee
Department of Surgery, University of Colorado Health Sciences Center, Denver 80262, USA.

The signal transduction of ischemic preconditioning involves activation of endogenous receptor-based systems, including alpha 1-adrenoceptors and adenosine receptors. Whereas preconditioning protects against ischemia-reperfusion injury, it is unknown whether this protective strategy might be useful clinically. Furthermore, human atrium has been successfully preconditioned, but it is unknown whether human ventricle can be functionally protected against hypoxia-reoxygenation. To study these questions, isolated rat ventricle and human ventricular trabeculae were suspended in an organ bath and subjected to 30 min of hypoxia and 60 min of reoxygenation. In the rat ventricle, preconditioning was induced by 5 min of rapid pacing at 3 Hz in hypoxic buffer without glucose (simulated ischemia), alpha 1-adrenoceptor stimulation (phenylephrine), or adenosine receptor stimulation (adenosine). In the human trabeculae the effects of preceding simulated ischemia and alpha 1-adrenoceptor and adenosine receptor stimulation were examined against hypoxia-reoxygenation. In the rat, pretreatment with simulated ischemia and alpha 1-adrenoceptor and adenosine receptor stimulation improved recovery of developed tension (56 +/- 3, 56 +/- 4, and 58 +/- 2%, respectively) compared with control trabeculae (25 +/- 2%) after hypoxia-reoxygenation (P < 0.05). In human trabeculae, simulated ischemic preconditioning and alpha 1-adrenoceptor and adenosine receptor stimulation augmented recovery of developed tension (65 +/- 5, 59 +/- 6, and 60 +/- 3%, respectively) compared with control (29 +/- 2%) after hypoxia-reoxygenation (P < 0.05). We conclude that functional cardioadaptation (preconditioning) against hypoxia-reoxygenation injury in rat and human myocardium exists and that alpha 1-adrenergic and adenosine receptor signaling participate in conferring this protection.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Han, N. Kim, H. Joo, and E. Kim
Ketamine abolishes ischemic preconditioning through inhibition of KATP channels in rabbit hearts
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H13 - H21.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. K. Gamperl, A. E. Todgham, W. S. Parkhouse, R. Dill, and A. P. Farrell
Recovery of trout myocardial function following anoxia: preconditioning in a non-mammalian model
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1755 - R1763.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Loubani and M. Galinanes
{{alpha}}1-Adrenoceptors during simulated ischemia and reoxygenation of the human myocardium: Effect of the dose and time of administration
J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 103 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. J. Pomerantz, T. N. Robinson, T. D. Morrell, J. K. Heimbach, A. Banerjee, and A. H. Harken
Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium
J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 387 - 392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. M. Hohl
AMP deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia
Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1502 - H1510.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. R. Meldrum
Tumor necrosis factor in the heart
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R577 - R595.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. C. Cleveland Jr, D. R. Meldrum, B. S. Cain, A. Banerjee, and A. H. Harken
Oral Sulfonylurea Hypoglycemic Agents Prevent Ischemic Preconditioning in Human Myocardium : Two Paradoxes Revisited
Circulation, July 1, 1997; 96(1): 29 - 32.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken
Preconditioning and Hypothermic Cardioplegia Protect Human Heart Equally Against Ischemia
Ann. Thorac. Surg., January 1, 1997; 63(1): 147 - 152.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online